Evaluating and treating eye diseases
Studies of the Natural History, Pathogenesis and Outcome of Ocular Disorders
National Institutes of Health Clinical Center (CC) · NCT02821767
This study is testing standard treatments for different eye diseases in people to see how well they work and to gather information for future research.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 1 Month to 100 Years |
| Sex | All |
| Sponsor | National Institutes of Health Clinical Center (CC) (nih) |
| Locations | 1 site (Bethesda, Maryland) |
| Trial ID | NCT02821767 on ClinicalTrials.gov |
What this trial studies
The National Eye Institute (NEI) is conducting an observational study to evaluate and provide standard treatment for individuals with various eye diseases. Participants will undergo a series of eye exams and assessments over a period of up to five years, with visits ranging from one to twelve times per year based on their specific condition. The study aims to collect data and specimens to enhance understanding of eye diseases, their inheritance, and the effectiveness of standard treatments. Additionally, it seeks to establish a resource for future research on ocular conditions.
Who should consider this trial
Good fit: Ideal candidates include individuals with diagnosed, undiagnosed, or suspected eye diseases who can provide informed consent.
Not a fit: Patients with systemic diseases that hinder adequate ophthalmologic examination or treatment may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and treatment options for patients with eye diseases.
How similar studies have performed: Other studies focusing on the natural history and treatment of ocular diseases have shown promise, indicating that this approach is supported by previous findings.
Eligibility criteria
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA: To be eligible, the following inclusion criteria must be met, where applicable. 1. Have a diagnosed, undiagnosed or suspected eye disease. 2. Have the ability to understand and sign an informed consent or have a parent/legal guardian do so if they are minor children or a legally authorized representative to provide consent for adults without consent capacity. EXCLUSION CRITERIA: A participant is not eligible if any of the following exclusion criteria are present. 1. Are unwilling to give informed consent or assent when applicable. 2. Are unwilling or unable to be followed as clinically indicated. 3. Have a systemic disease that compromises the ability of NEI clinicians to provide adequate ophthalmologic examination or treatment.
Where this trial is running
Bethesda, Maryland
- National Institutes of Health Clinical Center — Bethesda, Maryland, United States (RECRUITING)
Study contacts
- Principal investigator: Awilda V Holland, R.N. — National Eye Institute (NEI)
- Study coordinator: Awilda V Holland, R.N.
- Email: aholland@nei.nih.gov
- Phone: (301) 435-1831
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Eye Disease, Natural History